Saturday, July 11, 2026

Drug profile · INN

carrellizumab

carrellizumab is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — carrellizumab
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

carrellizumab is an FDA-listed pharmaceutical active ingredient.

Key facts

INN carrellizumab

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Carrellizumab + Capecitabine Phase 3 · Sun Yat-sen Memorial · Breast Neoplasms

Frequently asked questions

What is carrellizumab?

carrellizumab is an FDA-listed pharmaceutical active ingredient.